Cesarean Section Complications
0
Pipeline Programs
2
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
Human BioSciencesEmpowered Relief
Human BioSciencesEmpowered Relief
Human BioSciencesEmpowered Relief
Raydiant OximetryDAISY Uterine Drain
Clinical Trials (4)
Total enrollment: 180 patients across 4 trials
Reducing Chronic Pain Following Cesarean Delivery
Start: Oct 2026Est. completion: Mar 202730 patients
N/ARecruiting
Empowered Relief for Severe Pain After Cesarean Delivery During the Inpatient Period
Start: Oct 2026Est. completion: Apr 202760 patients
N/ANot Yet Recruiting
Using Empowered Relief and Education To Help Postpartum Women Recover After Cesarean Delivery
Start: Dec 2025Est. completion: Dec 202780 patients
N/AEnrolling By Invitation
DAISY Uterine Drain Device Evaluation
Start: May 2024Est. completion: Apr 202510 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 180 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.